Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

224.60
Delayed Data
As of Jun 27
 -4.42 / -1.93%
Today’s Change
223.02
Today|||52-Week Range
412.24
-26.69%
Year-to-Date
Trader's Daily Notebook: If There's a Bounce, It Won't Last Long
7:06am / TheStreet.com - Paid Partner Content
RBC sees biopharma 'insulated' from Brexit, says buy Celgene for bounceback
Jun 24 / TheStreet.com - Paid Partner Content
3 Reasons Anavex Stock Could Rise
Jun 27 / MotleyFool.com - Paid Partner Content
Better Buy: Biogen Inc. vs. Celgene Corporation
Jun 23 / MotleyFool.com - Paid Partner Content
A Biotech Stock Turnaround Requires an Alzheimer's Drug Miracle
Jun 27 / TheStreet.com - Paid Partner Content
Cramer: Why Can't We Get Together on Mergers?
Jun 22 / TheStreet.com - Paid Partner Content
Think of This Stock as Buy-ogen
Jun 25 / TheStreet.com - Paid Partner Content
Why Biogen Inc. Is Down 22.5% In 2016
Jun 21 / MotleyFool.com - Paid Partner Content
2 Biotech Stocks That Won't Pay a Dividend Anytime Soon, and 1 That Should
Jun 24 / MotleyFool.com - Paid Partner Content
These 5 Biotech Stocks Are Ridiculously Cheap
Jun 21 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close229.02
Today’s open227.00
Day’s range223.02 - 229.54
Volume2,929,862
Average volume (3 months)1,785,119
Market cap$49.2B
Dividend yield--
Data as of 06/27/2016

Growth & Valuation

Earnings growth (last year)+24.01%
Earnings growth (this year)+11.01%
Earnings growth (next 5 years)+9.50%
Revenue growth (last year)-3.87%
P/E ratio13.8
Price/Sales7.60
Price/Book5.24

Competitors

 Today’s
change
Today’s
% change
BAXBaxter International...-1.50-3.42%
JUNOJuno Therapeutics In...-3.02-7.47%
CTLTCatalent Inc-1.50-6.58%
XONIntrexon Corp-0.01-0.04%
Data as of 06/27/2016

Financials

Next reporting dateJuly 19, 2016
EPS forecast (this quarter)$4.68
Annual revenue (last year)$9.3B
Annual profit (last year)$3.5B
Net profit margin38.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
George A. Scangos
Chief Scientific Officer &
Executive VP
Spyridon Artavanis-Tsakonas
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs